Insights into the complexity of SARS-CoV-2 M pro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme
Journal of Enzyme Inhibition and Medicinal Chemistry · 2026
DOI: 10.1080/14756366.2025.2604232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2026. Verfasst von Simone Fabbian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Organoselenium Compounds, SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, NextGenerationEU, Università degli Studi di Padova.
Abstract (Originalsprache)
The SARS-CoV-2 Main Protease (Mpro), a key enzyme for viral replication, represents a highly attractive target for the development of broad-spectrum anti-coronavirus therapeutics. The organoselenium drug Ebselen has shown potent in vitro inhibition of Mpro as well as antiviral activity, granting clinical interest as a COVID-19 treatment option. Here we show that Ebselen and selected derivatives with human neutrophil elastase (HNE) inhibition and anti-radical activity are able to bind covalently to the viral enzyme with multiple stoichiometry, exhibiting inhibitory activity towards SARS-CoV-2 Mpro with potencies in the nanomolar range. Employing a mass spectrometry-based approach, we show that, upon binding to the target, Ebselen and its derivatives induce a dose-dependent shift in the dimer-monomer equilibrium, favouring the inactive monomeric state of the viral protease and possibly contributing to the observed in vitro inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
- Department of Molecular Medicine, University of Padova, Padova, Italy.
- NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.
- Department of Chemical Sciences, University of Padova, Padova, Italy.
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- NextGenerationEU
- Università degli Studi di Padova
Zitieren
APA
Fabbian, S., Fabi, S., Schwarz, L., Preto, G., Schiavinato, C., Salata, C., Crocetti, L., Battistutta, R., Gatto, B., & Sosic, A. (2026). Insights into the complexity of SARS-CoV-2 M pro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2025.2604232
Vancouver
Fabbian S, Fabi S, Schwarz L, Preto G, Schiavinato C, Salata C, et al. Insights into the complexity of SARS-CoV-2 M pro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026. doi:10.1080/14756366.2025.2604232
BibTeX
@article{Fabbian2026,
author = {Fabbian, Simone and Fabi, Silvia and Schwarz, Laurin and Preto, Giovanni and Schiavinato, Chiara and Salata, Cristiano and Crocetti, Letizia and Battistutta, Roberto and Gatto, Barbara and Sosic, Alice},
title = {Insights into the complexity of SARS-CoV-2 M pro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2026},
doi = {10.1080/14756366.2025.2604232}
}
EUVIMED